Gormley Appointed Editor of the Journal of Drugs in Dermatology
Gormley, who is an award-winning journalist, author, and medical editor, brings with him 20 years of healthcare communication, publication management, and scientific affairs experience.
“I’m so happy that James has joined our team, especially at this time, as he brings with him a wealth of healthcare communication experience, including having co-authored peer-reviewed scientific review articles and chapters on nutraceuticals,” says
“Along with Co-Editor-in-Chief Dr.
“I am honored and thrilled to be working with the guidance of such renowned dermatology thought leaders as Dr.
“Along with my talented and dedicated editorial colleagues here, namely
The Journal of Drugs in Dermatology is a peer-reviewed, MEDLINE/PubMed-indexed journal committed to advancing clinical knowledge and discovery in dermatology, including original articles and case reports that deliver cutting-edge clinical practice science and insights relating to methods, techniques, technologies, devices, and drug therapies in dermatology. PCE is a multimedia publisher and events producer that comprises several businesses, including JDD, PCE Publishing (www.pceny.com), ODAC/Orlando Dermatology Aesthetic & Clinical Conference (www.orlandoderm.org), and Educational Testing and Assessment Systems (www.etasonline.com). For more information about JDD, please call 212-213-5434 or visit www.jddonline.com.
SOURCE Physicians’ Continuing Education